Anisa Scott

Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents.

Laura G. Dubois, Philip F. Hughes, J. Strachan, 2009, Journal of medicinal chemistry.

SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase–Dependent Cancers

Sarat Chandarlapaty, Neal Rosen, David B. Solit, 2008, Clinical Cancer Research.

Identification of Novel Pheromone-response Regulators through Systematic Overexpression of 120 Protein Kinases in Yeast*

Henrik G. Dohlman, B. Errede, H. Dohlman, 2001, The Journal of Biological Chemistry.

Purification of a 12,020-Dalton Protein That Enhances the Activation of Mitogen-activated Protein (MAP) Kinase by MAP Kinase Kinase (*)

T. Haystead, C. Haystead, Anisa Scott, 1995, The Journal of Biological Chemistry.

Brain-Permeable Small-Molecule Inhibitors of Hsp90 Prevent α-Synuclein Oligomer Formation and Rescue α-Synuclein-Induced Toxicity

Carol D. Hicks, B. Hyman, J. Veal, 2010, Journal of Pharmacology and Experimental Therapeutics.

Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90.

Briana Foley, Laura G. Dubois, Philip F. Hughes, 2010, Chemistry & biology.

The use of high-content screening for the discovery and characterization of compounds that modulate mitotic index and cell cycle progression by differing mechanisms of action.

J. Rice, A. Barabasz, Briana E. Foley, 2006, Assay and drug development technologies.

545 POSTER SNX-2112: a novel, selective, potent small molecule inhibitor of Hsp90 with unique pharmacodynamic properties

P. Fadden, S. Hall, A. Barbasz, 2006 .

Targeting of multiple signaling pathways by the Hsp90 inhibitor SNX-2112 in EGFR resistance models as a single agent or in combination with erlotinib.

J. Veal, P. Fadden, S. Hall, 2009, Oncology research.